Research ArticleOriginal Article
Open Access

Effect of a low dose of empagliflozin on short-term outcomes in type 2 diabetics with acute coronary syndrome after percutaneous coronary intervention

Seyed Mohammad H. Adel, Fateme Jorfi, Hoda Mombeini, Homeira Rashidi and Saad Fazeli
Saudi Medical Journal May 2022, 43 (5) 458-464; DOI: https://doi.org/10.15537/smj.2022.43.5.20220018

Article Information

vol. 43 no. 5 458-464
DOI 
https://doi.org/10.15537/smj.2022.43.5.20220018
PubMed 
35537720
Published By 
Saudi Medical Journal
Online ISSN 
1658-3175
History 
  • Received January 8, 2022
  • Accepted April 10, 2022
  • Published online May 10, 2022.
Copyright & Usage 
Copyright: © Saudi Medical Journal This is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work.

Author Information

  1. Seyed Mohammad H. Adel, MD⇑,
  2. Fateme Jorfi, MD,
  3. Hoda Mombeini, MD,
  4. Homeira Rashidi, MD and
  5. Saad Fazeli, MD
  1. From the Department of Cardiology (Adel, Jorfi, Mombeini, Fazeli), from the Atherosclerosis Research Center (Adel, Jorfi, Mombeini), and from the Department of Internal Medicine (Rashidi), Ahvaz Jundishapur University of Medical Sciences, Imam Khomeini Hospital, Ahvaz, Iran.
  1. Address correspondence and reprint request to: Dr. Seyed Mohammad H. Adel, Department of Cardiology, Ahvaz Jundishapur University of Medical Sciences, Imam Khomeini Hospital, Ahvaz, Iran. E-mail: dr.hassan.adel{at}gmail.com ORCID ID: https://orcid.org/0000000171650295
View Full Text

Cited By...

Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords